Related Experiment Video
Updated: Nov 4, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Are Financial Incentives Appropriate Means of Encouraging Medication Adherence Among People Living With HIV?
Toorjo Ghose1, Virginia Shubert2, Sambuddha Chaudhuri3
1Associate professor in the School of Social Policy and Practice at the University of Pennsylvania in Philadelphia.
Background:
Financial incentives have been shown to improve antiretroviral (ARV) adherence for people living with HIV, but scholars have argued that this commodifies treatment and have debated the ethics of doing so. This article summarizes research on ethical processes and factors involved in an intervention that successfully improved ARV adherence among socially vulnerable people living with HIV.
Methods:
Thirty qualitative interviews were conducted with intervention participants and field notes documenting organizational processes were analyzed. The protocol utilized a preexisting framework to assess the ethics of using financial incentives to motivate adherence.
Results:
Financial incentives supported an ethical service provision framework by (1) establishing and strengthening client agency, (2) revising organizational protocols to prioritize adherence, and (3) promoting resource redistribution.
Conclusions:
Financial incentives, when embedded in wrap-around services, innovative client-centered organizational processes, and a justice orientation, constitute an ethical intervention requiring ethical investigation.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Heart Failure V: Medical Management
Therapeutic Drug Monitoring: Affecting Factors
Retrovirus Life Cycles
Sexually Transmitted Infections

